Protara Therapeutics TARA
NASDAQ TARA
$2.74 -0.02 (-0.54%)
As of: Oct 2, 2026 · 10:03 AM EDT

Protara Therapeutics (TARA) Non Operating Income (2013 - 2026)

Updated

Protara Therapeutics' Non Operating Income was $1.66 million in Q2 2026, up 1.8% from $1.63 million a year earlier but down 10.3% from the prior quarter.

Analysis

Protara Therapeutics (TARA) Non Operating Income (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Protara Therapeutics' Non Operating Income was $6.78 million through Jun 30, 2026, up 4.4% year-over-year; for FY2025, it came in at $7.11 million, up 56.0% from FY2024.

  • Non Operating Income has now increased for four consecutive years, with a five-year compound annual growth rate of 72.5% (FY2020 to FY2025).
  • In earlier years, Non Operating Income was $4.56 million in FY2024 (+42.7%), $3.19 million in FY2023 (+187.7%), $1.11 million in FY2022 (+368.4%) and $237,000 in FY2021 (-49.1%).
  • Quarterly Non Operating Income has moved between $53,000 (Q3 2021) and $2.21 million (Q1 2025) over five years.
  • Compared with a year earlier, Non Operating Income was higher in seven of the last eight quarters, with growth averaging 48.7%.
  • The best year-over-year quarter for Non Operating Income over five years was Q4 2022 (growth of 818.6%); the worst was Q4 2021 (a decline of 60.4%).
  • Per Business Quant data, TARA's Non Operating Income in the three quarters before Q2 2026 was $1.85 million (Q1 2026), $1.77 million (Q4 2025) and $1.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Protara Therapeutics 180.21 Mn 180.21 Mn - 1.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.66 Mn
Mar 31, 2026 1.85 Mn
Dec 31, 2025 1.77 Mn
Sep 30, 2025 1.50 Mn
Jun 30, 2025 1.63 Mn
Mar 31, 2025 2.21 Mn
Dec 31, 2024 1.54 Mn
Sep 30, 2024 1.11 Mn
Jun 30, 2024 1.15 Mn
Mar 31, 2024 756,000.00
Dec 31, 2023 820,000.00
Sep 30, 2023 840,000.00
Jun 30, 2023 846,000.00
Mar 31, 2023 687,000.00
Dec 31, 2022 542,000.00
Sep 30, 2022 283,000.00
Jun 30, 2022 166,000.00
Mar 31, 2022 119,000.00
Dec 31, 2021 59,000.00
Sep 30, 2021 53,000.00
API Access

Protara Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=TARA&period=max&api_key=YOUR_API_KEY